glp-1 medications for obesity Infographic What's New in Obesity Treatment?

Semaglutide and Reproductive Hormone Shifts Semaglutide itself does not directly alter hormone production

adjusted HR 1.18)

In patients without cirrhosis, 4565 (31.2%) switched from a DPP-4i to a GLP-1 RA, and 965 GLP-1 RA users (6.6%) switched to a DPP-4i during follow-up

Bloating and Farting These uncomfortable side effects were reported in clinical trials as abdominal distension and flatulence. Bloating and farting complaints are less common than the gastrointestinal effects discussed above, and they have yet to catch on as hot topics on social media, but its good to know that Ozempic and related drugs may increase their likelihood

You could see changes in digestion and appetite in about 2 to 4 weeks if you stay consistent

But as we age, or experience chronic stress, perimenopause, menopause, or andropause, these hormones can fall out of sync and optimal levels may decrease